Navigation Links
Chan Zuckerberg Biohub Choose Geneious For Best Practice NGS Antibody Pipeline
Date:4/8/2019

To support the global fight against existing and emerging infectious disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen Geneious Biologics to help them analyze and compare human antibody repertoires. The study of antibody repertoires is part of CZ Biohub’s efforts to establish new approaches to inform the discovery of antibody-based diagnostics, new therapies and the design of recombinant protein vaccines. Together with collaborators, CZ Biohub and Geneious are working towards standardizing the analysis and use of immune receptor repertoire data.

Krista McCutcheon Group Leader, Antibody Discovery at CZ Biohub: "The commitment, expertise and collaborative nature of the Geneious team has allowed us to deliver on our internal goal of providing a software pipeline for NGS antibody data analysis and visualization aligned with the best practices in the field."

Geneious Biologics is Biomatters’ cloud-based enterprise software solution for analysis of antibodies and related constructs using NGS or Sanger sequence data. The CZ Biohub are profiling B cell repertoires circulating in human blood in order to understand the history, evolution, memory, and molecular determinants of successful and failed immune responses to pathogens. The Antibody Discovery group then aims to identify and elicit defined specificities of memory B cells to protect diverse human populations around the globe.

Biomatters CEO Brett Ammundsen: “We are delighted to have been chosen by the CZ Biohub to support their mission to solve big health problems, particularly because of their philosophy of using the best scientific tools available. CZ Biohub is setting the standard for the industry and it’s fantastic to be playing a role in that.”

About Geneious and Biomatters
Biomatters empowers its customers with software that transforms biological data into knowledge and actionable insights across the spectrum of biotechnology research and development, including drug discovery, protein engineering and advanced comparative analysis of DNA, RNA and protein sequences. Geneious solutions are created from a deep understanding of customer experience and turn the difficult into the intuitive and easy. That is why Geneious is trusted by over 4,000 companies, universities and institutes all over the globe. https://www.geneious.com/

About the Chan Zuckerberg Biohub
The CZ Biohub is an independent non-profit medical research organization collaborating with the University of California, Berkeley, Stanford University and the University of California, San Francisco. The organization’s goal is to harness the power of science, technology and human capacity to cure, prevent or manage all disease during our children’s lifetime. For more information about the CZ Biohub, visit https://czbiohub.org.

Read the full story at https://www.prweb.com/releases/chan_zuckerberg_biohub_choose_geneious_for_best_practice_ngs_antibody_pipeline/prweb16226357.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial
2. DaVita Clinical Research and Prism Clinical Research Choose Verified Clinical Trials to Prevent Duplicate Enrollment in Clinical Trials
3. Boston-Based CIC Chooses uCity Square for Newest Expansion Location
4. ChooseATL and the Metro Atlanta Chamber Launch New Speaker Series, JAM Session
5. Boehringer Ingelheim Chooses Genedata Selector(TM) for Cell Line Development and Cell Culture Optimization
6. Merck Serono Chooses Genedata Biologics to Streamline Antibody Discovery Processes
7. Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014
8. Namdhari Seeds, One of India’s Largest Seed Companies, Chooses Phenome Networks for Plant Breeding Management
9. Michigan State Police Chooses More Software from STACS DNA
10. PrimeSource Chooses SoundConnect as Collaboration Provider
11. Extreme Sport Athletes Choose the Rebound® TENS Unit at Clash at Clairemont 8
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2019)... ... April 16, 2019 , ... ... their project partner, the U.S. Army Center for Environmental Health Research (USACEHR), with ... Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company located at the Frederick Innovative ...
(Date:4/10/2019)... ... April 10, 2019 , ... After more than three months ... new kitchen is equipped with updated appliances and modern lighting and fixtures, and will ... , “We’ve seen tremendous growth in the demand for our team-building events ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global Securities ... million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). , ... is targeted at female hypoactive sexual dysfunction disorder and is ready to begin phase ...
(Date:3/27/2019)... ... March 26, 2019 , ... A leader in the field of ... veterinarians across the United States and Canada since 2004. The primary indications for ... injuries in the dog, cat, and horse. Recently, VetStem teamed up with ...
Breaking Biology Technology:
(Date:3/29/2019)... ... March 28, 2019 , ... In the wake of ... entirely dedicated to Chinese biobanks was launched in July 2018, in an agreement ... Biobank Branch, China Medicinal Biotech Association (BBCMBA). The one-year pilot programme offered two ...
(Date:3/27/2019)... ... March 27, 2019 , ... NDA Partners Chief Executive Officer ... Health & Pharma Biotechnology Award as the Best Life Sciences Management & Contract ... individuals and companies whose accomplishments have proved evidence of extensive expertise and skills, ...
(Date:3/25/2019)... , ... March 25, 2019 , ... ... Visikol, a contract research organisation focused on advancing drug discovery, have announced a ... imaging. , Tissue clearing methods, which are essential to get a better view ...
Breaking Biology News(10 mins):